Avectas collaborates with CCRM on cell engineering tech
The two partners will look to accelerate the development of Avectas’ Solupore platform for the development of immuno-oncology and gene therapies.
The two partners will look to accelerate the development of Avectas’ Solupore platform for the development of immuno-oncology and gene therapies.
The Korean CDMO signs a partnership deal with STCube for the development of a STT-003 targeting antibody, which is approaching the IND stage.
Increased manufacturing demands for cell and gene therapies drive the growth of the viral vector supply market, but challenges are still to be addressed, says Symbiosis.
Biogen signs a partnership agreement with Sangamo for the use of zinc-finger technology to progress various neurological disease candidates.